EndoGastric Solutions Stock

endogastricsolutions.comHealthcare / Medical DevicesFounded: 2003Funding to Date: $189MM

EndoGastric Solutions is a medical device company focused on developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of gastroesophageal reflux disease (GERD).

Register To Buy and Sell Private Company Shares

For more details on private stock price information, financing and valuation for EndoGastric Solutions, register or login.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Private Market Pricing DetailsValuation & Financings

EndoGastric Solutions Stock Price

Forge Price 1
Price not yet available
Last Closed Trade 2
Close Date
xx/xx/xx
Last Closed Trade Price
$xx.xx
Last Funding Round (LFR)
Date
xx/xx/xx
Price per Share
$xx.xx

EndoGastric Solutions Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
11/25/2020 Series J $27MM $xx.xx $448.42MM Vertex Growth Fund
Price per Share
$xx.xx
Shares Outstanding
10,751,404
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
2.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Vertex Growth Fund
05/28/2019 Series I $45MM $xx.xx $380.74MM Advanced Technology Ventures, Canaan Partners, Chicago Growth Partners, CRG, Radius Ventures, Sightline Partners
Price per Share
$xx.xx
Shares Outstanding
19,710,907
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
3.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Advanced Technology Ventures, Canaan Partners, Chicago Growth Partners, CRG, Radius Ventures, Sightline Partners
07/10/2018 Series H $15.2MM $xx.xx $138.45MM Advanced Technology Ventures, Canaan Partners, Canepa Healthcare, Chicago Growth Partners, CRG, Radius Ventures, Sightline Partners
Price per Share
$xx.xx
Shares Outstanding
16,641,936
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Advanced Technology Ventures, Canaan Partners, Canepa Healthcare, Chicago Growth Partners, CRG, Radius Ventures, Sightline Partners
05/06/2014 Series G-1 $9.43MM $xx.xx $196.98MM Advanced Technology Ventures, Canaan Partners, Chicago Growth Partners, De Novo Ventures, Foundation Medical Partners, Oakwood Medical Investors, Radius Ventures
Price per Share
$xx.xx
Shares Outstanding
10,322,523
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Advanced Technology Ventures, Canaan Partners, Chicago Growth Partners, De Novo Ventures, Foundation Medical Partners, Oakwood Medical Investors, Radius Ventures
05/06/2014 Series G $20.46MM $xx.xx $196.98MM Advanced Technology Ventures, Canaan Partners, Chicago Growth Partners, De Novo Ventures, Foundation Medical Partners, Oakwood Medical Investors, Radius Ventures
Price per Share
$xx.xx
Shares Outstanding
22,399,660
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Advanced Technology Ventures, Canaan Partners, Chicago Growth Partners, De Novo Ventures, Foundation Medical Partners, Oakwood Medical Investors, Radius Ventures
06/21/2012 Series F $37.17MM $xx.xx $146.9MM Advanced Technology Ventures, Canaan Partners, Chicago Growth Partners, De Novo Ventures, Foundation Medical Partners, Oakwood Medical Investors, Radius Ventures
Price per Share
$xx.xx
Shares Outstanding
40,700,693
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Advanced Technology Ventures, Canaan Partners, Chicago Growth Partners, De Novo Ventures, Foundation Medical Partners, Oakwood Medical Investors, Radius Ventures
11/25/2009 Series E $15.26MM $xx.xx $109.8MM Advanced Technology Ventures
Price per Share
$xx.xx
Shares Outstanding
9,391,061
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Advanced Technology Ventures
08/31/2007 Series D $8.54MM $xx.xx $98.28MM Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
4,126,926
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
02/23/2006 Series C $8.89MM $xx.xx $59.62MM Chicago Growth Partners
Price per Share
$xx.xx
Shares Outstanding
6,041,662
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Chicago Growth Partners
09/11/2004 Series B $1.31MM $xx.xx $11.18MM MPM Capital, Advanced Technology Ventures, Foundation Medical Partners
Price per Share
$xx.xx
Shares Outstanding
2,399,998
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
MPM Capital, Advanced Technology Ventures, Foundation Medical Partners
04/08/2003 Series A $737,298 $xx.xx $4.92MM MPM Capital, Advanced Technology Ventures, Foundation Medical Partners
Price per Share
$xx.xx
Shares Outstanding
1,683,329
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
MPM Capital, Advanced Technology Ventures, Foundation Medical Partners

Leadership & Board

Leadership

Steve Hoffman
Corporate Compliance Officer
Michael Burke
Chief Financial Officer
Sheryl McCalman
Director, Finance & Controller
Louis Baldino
President, Board Member & Chief Executive Officer
Adrian Lobontiu MD
Chief Medical Officer

Board

Alejandro Sanchez
Evidity Health Capital
Jordan Davis
Radius Ventures
Michael Carusi
Advanced Technology Ventures
Uri Geiger Ph.D
Accelmed
Arda Minocherhomjee Ph.D
Chicago Growth Partners
Louis Baldino
Brent Ahrens
Canaan Partners
Kunal Paymaster
SightLine Partners
Scott Ward
SightLine Partners

EndoGastric Solutions stock FAQs

plusminus

Can you buy EndoGastric Solutions stock?

As EndoGastric Solutions is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private companies like EndoGastric Solutions, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.
plusminus

How to buy EndoGastric Solutions stock?

To invest in a private company like EndoGastric Solutions through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell EndoGastric Solutions stock?

Yes, you may sell the EndoGastric Solutions stock you currently own. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company’s interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell EndoGastric Solutions stock?

If you hold private company shares of EndoGastric Solutions – whether as an employee or an early investor – Forge can help you sell them.

  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your EndoGastric Solutions on our platform.
  3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.
plusminus

Is EndoGastric Solutions a public company?

No, EndoGastric Solutions is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is EndoGastric Solutions’ stock price?

EndoGastric Solutions is a privately held company and therefore does not have a public stock price. However, you may access EndoGastric Solutions private market stock price with Forge Data.
plusminus

What is EndoGastric Solutions’ stock ticker symbol?

EndoGastric Solutions does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

EndoGastric Solutions’ news and media highlights

Updated on: Nov 2, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge.  Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.